155 related articles for article (PubMed ID: 8421418)
1. Oncogenes in head and neck cancer.
Irish JC; Bernstein A
Laryngoscope; 1993 Jan; 103(1 Pt 1):42-52. PubMed ID: 8421418
[TBL] [Abstract][Full Text] [Related]
2. ras mutations and expression in head and neck squamous cell carcinomas.
Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM
Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162
[TBL] [Abstract][Full Text] [Related]
3. Amplification of epidermal growth factor receptor gene but no evidence of ras mutations in primary human esophageal cancers.
Hollstein MC; Smits AM; Galiana C; Yamasaki H; Bos JL; Mandard A; Partensky C; Montesano R
Cancer Res; 1988 Sep; 48(18):5119-23. PubMed ID: 3044581
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
[TBL] [Abstract][Full Text] [Related]
5. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
Chung CH; Ely K; McGavran L; Varella-Garcia M; Parker J; Parker N; Jarrett C; Carter J; Murphy BA; Netterville J; Burkey BB; Sinard R; Cmelak A; Levy S; Yarbrough WG; Slebos RJ; Hirsch FR
J Clin Oncol; 2006 Sep; 24(25):4170-6. PubMed ID: 16943533
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of RAS oncogene mutation in head and neck carcinomas.
Anderson JA; Irish JC; Ngan BY
J Otolaryngol; 1992 Oct; 21(5):321-6. PubMed ID: 1361585
[TBL] [Abstract][Full Text] [Related]
7. Amplification of the int-2 gene in human head and neck squamous cell carcinomas.
Somers KD; Cartwright SL; Schechter GL
Oncogene; 1990 Jun; 5(6):915-20. PubMed ID: 2193294
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer.
Temam S; Kawaguchi H; El-Naggar AK; Jelinek J; Tang H; Liu DD; Lang W; Issa JP; Lee JJ; Mao L
J Clin Oncol; 2007 Jun; 25(16):2164-70. PubMed ID: 17538160
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the epidermal growth factor receptor gene in fresh human head and neck tumors.
Eisbruch A; Blick M; Lee JS; Sacks PG; Gutterman J
Cancer Res; 1987 Jul; 47(13):3603-5. PubMed ID: 3581091
[TBL] [Abstract][Full Text] [Related]
10. [Oncogenes in squamous epithelial cancers in the area of the head and neck].
Volling P; Jungehülsing M; Tesch H; Stennert E
Laryngol Rhinol Otol (Stuttg); 1988 Apr; 67(4):160-4. PubMed ID: 3386367
[TBL] [Abstract][Full Text] [Related]
11. Oncogenes related to head and neck cancer.
Issing WJ; Wustrow TP; Heppt WJ
Anticancer Res; 1993; 13(6B):2541-51. PubMed ID: 8135494
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of the p53 gene status of lymph node metastasis in the head and neck region in occult primary cancer].
Gottschlich S; Schuhmacher O; Görögh T; Hoffmann M; Maune S
Laryngorhinootologie; 2000 Jul; 79(7):434-7. PubMed ID: 11005098
[TBL] [Abstract][Full Text] [Related]
13. Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma.
Fenic I; Steger K; Gruber C; Arens C; Woenckhaus J
Oncol Rep; 2007 Jul; 18(1):253-9. PubMed ID: 17549376
[TBL] [Abstract][Full Text] [Related]
14. Role of epidermal growth factor receptor overexpression, K-ras point mutation and c-myc amplification in the carcinogenesis of non-small cell lung cancer.
Sekine I; Takami S; Guang SG; Yokose T; Kodama T; Nishiwaki Y; Kinoshita M; Matsumoto H; Ogura T; Nagai K
Oncol Rep; 1998; 5(2):351-4. PubMed ID: 9468555
[TBL] [Abstract][Full Text] [Related]
15. Expression status and mutational analysis of the ras and B-raf genes in ovarian granulosa cell and epithelial tumors.
Jamieson S; Alexiadis M; Fuller PJ
Gynecol Oncol; 2004 Dec; 95(3):603-9. PubMed ID: 15581971
[TBL] [Abstract][Full Text] [Related]
16. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
Sok JC; Coppelli FM; Thomas SM; Lango MN; Xi S; Hunt JL; Freilino ML; Graner MW; Wikstrand CJ; Bigner DD; Gooding WE; Furnari FB; Grandis JR
Clin Cancer Res; 2006 Sep; 12(17):5064-73. PubMed ID: 16951222
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
[TBL] [Abstract][Full Text] [Related]
18. Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas.
Berenson JR; Yang J; Mickel RA
Oncogene; 1989 Sep; 4(9):1111-6. PubMed ID: 2476705
[TBL] [Abstract][Full Text] [Related]
19. [Oncogenic activity of head and neck tumors].
Basterra J; Armengot M; Martorell M; Barona R; Montalt J
An Otorrinolaringol Ibero Am; 1995; 22(2):197-206. PubMed ID: 7778721
[TBL] [Abstract][Full Text] [Related]
20. Further evidence for prognostic significance of epidermal growth factor receptor gene amplification in patients with esophageal squamous cell carcinoma.
Kitagawa Y; Ueda M; Ando N; Ozawa S; Shimizu N; Kitajima M
Clin Cancer Res; 1996 May; 2(5):909-14. PubMed ID: 9816249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
